Eyenovia Inc

NASDAQ:EYEN 4:00:00 PM EDT

0.51

-0.03 (-4.90%)

7:56:26 PM EDT: $0.53 +0.02 (+3.33%)

Market Cap (Intraday)	39.08M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.14 Million
Adjusted EPS	-$0.13

See more estimates

10-Day MA	$0.54
50-Day MA	$0.86
200-Day MA	$1.16

See more pivots

Eyenovia Inc Stock, NASDAQ:EYEN

295 Madison Avenue, Suite 2400, New York, New York 10017

United States of America

Phone: +1.833.393.6684

Number of Employees: 57

http://www.eyenovia.com

Description

Eyenovia, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of ophthalmology products. The company offers a piezo-print technology to deliver micro-doses of micro-therapeutics for the eyes. Its products include MicroProst, MicroStat, MicroTears, and MicroPine. The firm is currently focused on the late-stage development of microdosed medications for presbyopia, myopia progression, and mydriasis. The company was founded by Sean Ianchulev on March 12, 2014 and is headquartered in New York, NY.